- Mark Bello | June 29, 2011 8:41 AM | Farmington Hills, MI
Category:
Miscellaneous
The US Supreme Court was asked to decide whether or not a generic drug maker, which has complied with federal requirements to provide labeling similar to a brand-name drugs, should be liable for...
- David Mittleman | July 14, 2009 11:06 AM | Lansing, MI
Category:
FDA & Prescription Drugs
Roche Holdings AG, the maker of the acne medication Accutane, is pulling the product from the U.S. market, citing “economic reasons”. However, juries have awarded at least $33 million in...
- David Mittleman | February 19, 2010 10:00 AM | Lansing, MI
Category:
FDA & Prescription Drugs
A New Jersey jury ordered Roche Holding AG to pay $25.16 million to a former Accutane user who blamed the acne medication for his inflammatory bowel disease. The man, 38-year-old Andrew McCarell,...